Biogened S.A. (WSE:BGD)

Poland flag Poland · Delayed Price · Currency is PLN
26.80
-3.40 (-11.26%)
At close: Jun 5, 2025
30.10%
Market Cap 65.83M
Revenue (ttm) 114.20M
Net Income (ttm) 4.78M
Shares Out 2.46M
EPS (ttm) 1.95
PE Ratio 13.77
Forward PE n/a
Dividend 0.50 (1.87%)
Ex-Dividend Date Sep 11, 2025
Volume 53
Average Volume 30
Open 32.00
Previous Close 30.20
Day's Range 26.80 - 32.00
52-Week Range 18.00 - 32.80
Beta 0.37
RSI 40.85
Earnings Date May 12, 2025

About Biogened

Biogened S.A. develops, produces, and distributes pharmaceutical products in Poland. The company offers dermo-cosmetics under the Dermedic brand; and thermal water. It also exports its products. The company was incorporated in 2007 and is headquartered in Lódz, Poland. [Read more]

Industry Pharmaceutical Preparations
Founded 2007
Employees 222
Stock Exchange Warsaw Stock Exchange
Ticker Symbol BGD
Full Company Profile

Financial Performance

In 2024, Biogened's revenue was 110.94 million, an increase of 16.09% compared to the previous year's 95.56 million. Earnings were 4.57 million, a decrease of -10.38%.

Financial Statements

News

There is no news available yet.